Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1

Background. Rapamycin (Rapa) is an immunosuppressant that is used in patients and animal models to control allograft rejection. Its mechanisms of action are not fully understood. In this article, the authors have investigated the effects of therapeutic doses of Rapa on both thymic and peripheral T-cell populations in the adult rat. Methods. The therapeutic dosage of Rapa was optimized using cardiac transplantation between LEW and DA rats. Thymic morphology was assessed by hematoxylin-eosin staining. Flow cytometric analysis was performed to analyze T-cell phenotype and apoptosis. T-cell receptor (TCR)-mediated T-cell responsiveness was evaluated by 3[H]-thymidine deoxyribose incorporation. Results. Rapa induced atrophy in the thymus but not in peripheral lymphoid organs. Moreover, fibrosis occurred in thymus that was long-lasting after Rapa withdrawal. In animals treated with Rapa, there was a significant reduction in CD4+CD8+ thymocytes caused by accelerated apoptosis, whereas CD4−CD8−, CD4+CD8−, and CD8+CD4− populations remained unaffected. In contrast, the cellularity of the periphery lymphoid organs was not altered. Within the CD4+ thymocyte population, CD4+CD25+ thymocytes were resistant to Rapa-accelerated apoptosis, and in the periphery, the ratio of CD4+CD25+ to CD4+CD25− T cells was increased. Notably, the peripheral CD4+CD25+ T cells were hyporesponsive to TCR-mediated activation. Conclusions. The resistance of the peripheral CD4+CD25+ T cells to Rapa treatment might contribute to its immunosuppressive action. The long-term effects of Rapa on thymus atrophy and thymocyte development requires consideration with respect to its clinical application.

[1]  M. Sayegh,et al.  New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs , 2002, Annals of surgery.

[2]  J. Bijlsma,et al.  Antigen‐specific T cell suppression by human CD4+CD25+ regulatory T cells , 2002, European journal of immunology.

[3]  M. Karim,et al.  CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses1 , 2002, The Journal of Immunology.

[4]  J. Camardo,et al.  Rapamycin: clinical results and future opportunities. , 2001, Transplantation.

[5]  Sayuri Yamazaki,et al.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance , 2001, Immunological reviews.

[6]  J. D. de Fijter,et al.  Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. , 2001, Blood.

[7]  H. Waldmann,et al.  Regulating the immune response to transplants. a role for CD4+ regulatory cells? , 2001, Immunity.

[8]  F. Powrie,et al.  IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.

[9]  M. Metcalfe,et al.  Rapamycin in transplantation: a review of the evidence. , 2001, Kidney international.

[10]  M. Hidalgo,et al.  The rapamycin-sensitive signal transduction pathway as a target for cancer therapy , 2000, Oncogene.

[11]  R. Morris,et al.  Graft-versus-host disease prevention by rapamycin: cellular mechanisms. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  L. Turka,et al.  Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. , 2000, Transplantation.

[13]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[14]  Liwei Lu,et al.  Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow , 2000, Immunological reviews.

[15]  S. Sakaguchi Regulatory T cells , 2000, Cell.

[16]  B. Haynes,et al.  The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.

[17]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[18]  R. Poston,et al.  Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. , 1999, Circulation.

[19]  R. Schwartz,et al.  Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.

[20]  R. Abraham,et al.  Immunopharmacology of rapamycin. , 1996, Annual review of immunology.

[21]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[22]  M. Kubo,et al.  T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection , 1995, The Journal of experimental medicine.

[23]  R. Abraham,et al.  Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. , 1995, Progress in cell cycle research.

[24]  Hongyu Luo,et al.  The effect of rapamycin on T cell development in mice , 1994, European journal of immunology.

[25]  D. Snover,et al.  Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome. , 1993, Journal of immunology.

[26]  B. Blazar,et al.  Rapamycin Prolongs Survival of Murine Recipients of Fully Allogeneic Donor Grafts When Administered during the Graft‐versus‐Host Disease Process a , 1993, Annals of the New York Academy of Sciences.

[27]  J. Sprent,et al.  Abnormal differentiation of thymocytes in mice treated with cyclosporin A , 1988, Nature.

[28]  R. Schwartz,et al.  Effects of cyclosporine A on T cell development and clonal deletion. , 1988, Science.